TLR9 and systemic lupus erythematosus: We observed that TLR7 or TLR9 agonists induce higher amounts of MCP-1 and IL-6 on PMs from lupus-prone mice than control mice, confirming that PMs from diseased mice present a more pro-inflammatory phenotype.